These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8071680)

  • 1. Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Preliminary report.
    Uzun O; Hayran M; Akova M; Gür D; Akalin HE
    J Chemother; 1994 Feb; 6(1):53-7. PubMed ID: 8071680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
    Bohte R; van't Wout JW; Lobatto S; Blussé van Oud Alblas A; Boekhout M; Nauta EH; Hermans J; van den Broek PJ
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):182-7. PubMed ID: 7614957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia.
    Rizzato G; Montemurro L; Fraioli P; Montanari G; Fanti D; Pozzoli R; Magliano E
    Eur Respir J; 1995 Mar; 8(3):398-402. PubMed ID: 7789484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
    Noreddin AM; El-Khatib WF; Aolie J; Salem AH; Zhanel GG
    Int J Infect Dis; 2009 Jul; 13(4):483-7. PubMed ID: 19046911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of sputum gram stain in the diagnosis of pneumococcal pneumonia.
    Aderaye G
    Ethiop Med J; 1994 Jul; 32(3):167-71. PubMed ID: 7525279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Azithromycin and bronchopulmonary infections].
    Leophonte P
    Pathol Biol (Paris); 1995 Jun; 43(6):534-41. PubMed ID: 8539078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx].
    Nariai A; Okitsu N; Inoue M
    Kansenshogaku Zasshi; 2004 Jun; 78(6):490-5. PubMed ID: 15287476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.
    San Pedro GS; Cammarata SK; Oliphant TH; Todisco T;
    Scand J Infect Dis; 2002; 34(10):720-8. PubMed ID: 12477321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
    Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
    Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Binax NOW Streptococcus pneumoniae test applied on nasopharyngeal aspirates to support pneumococcal aetiology in community-acquired pneumonia.
    Athlin S; Strålin K
    Scand J Infect Dis; 2013 Jun; 45(6):425-31. PubMed ID: 23330980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
    Drehobl MA; De Salvo MC; Lewis DE; Breen JD
    Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a Sputum Antigen Detection Test in Pneumococcal Pneumonia and Lower Respiratory Infectious Disease in Adults.
    Fukushima K; Nakamura S; Inoue Y; Higashiyama Y; Ohmichi M; Ishida T; Yoshimura K; Sawai T; Takayanagi N; Nakahama C; Kakugawa T; Izumikawa K; Aoki N; Nishioka Y; Kosaka O; Kohno S
    Intern Med; 2015; 54(22):2843-50. PubMed ID: 26567996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus.
    So W; Crandon JL; Nicolau DP
    Intern Emerg Med; 2016 Jun; 11(4):545-51. PubMed ID: 26531307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of the sputum gram's stain in community-acquired pneumonia.
    Boerner DF; Zwadyk P
    JAMA; 1982 Feb; 247(5):642-5. PubMed ID: 6172607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.
    Yoshioka D; Kajiwara C; Ishii Y; Umeki K; Hiramatsu K; Kadota J; Tateda K
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6146-54. PubMed ID: 27480866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of gram-stained sputum obtained just after administration of antimicrobial agents as the earliest therapeutic indicator for evaluating the effectiveness of empiric therapy in community-acquired pneumonia caused by pneumococcus or Moraxella catarrhalis.
    Fujisaki R; Yamaoka T; Yamamura M; Kawakami S; Ono Y; Miyazawa Y; Teramoto T; Nishiya H
    J Infect Chemother; 2013 Jun; 19(3):517-23. PubMed ID: 23073648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.